Back

Therapeutic potential of pxl065 (deuterium-stabilized r-enantiomer of pioglitazone) in hypertrophic cardiomyopathy

1 September 2025 (11:15 - 12:00)
Organised by: Logo
Congress Presentation Part of: Molecular networks and emerging therapeutics in cardiac pathophysiology Cardiomyopathies ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Ms Anna-Theresa Pfaller

German Heart Center of Munich, Munich (Germany)

6 More presentations in this session

Presentation thumbnail
Early life stress Induces age-dependent cardiac dysfunction in exposed parents and in their offspring
Doctor S. Mohammed (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
mRNA therapeutics encoding multiple cardiac-reparative factors using polyplex nanomicelle attenuating myocardial infarction
Doctor K. Handa (Suita, JP)
Abstract Slides Video
Presentation thumbnail
miR-125b-5p and miR-125b-1-3p mediate TGF-beta response in ischemic heart failure
Mr I. Hagerstrom (Helsingfors, FI)
Abstract Slides Video
Presentation thumbnail
Prime editing correction of an Nkx2-5 variant in a murine congenital heart disease model
Mr D. Nishijo (Tokyo, JP)
Abstract Slides Video
Presentation thumbnail
NRF2/beta3-adrenoreceptor signaling drives a sustained antioxidant and metabolic rewiring through the pentose-phosphate pathway to alleviate cardiac stress
Professor J. Balligand (Brussels, BE)
Abstract Slides Video

Access the full session

Session thumbnail
Molecular networks and emerging therapeutics in cardiac pathophysiology

The Event

Event poster

ESC Congress 2025

1 September 2025 11:15 CET
You may be interested in
thumbnail
Congress Presentation
Systematic evaluation of serial electrocardiographic changes in patients treated with mavacamten
thumbnail
Congress Presentation
Unravelling the progression of hypertrophic cardiomyopathy: computational insights into MYH7 mutations, ionic remodelling, hypertrophy, and targeted therapy development
thumbnail
Congress Presentation
BHB/HRS-1893 in non-obstructive hypertrophic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources